BEAM
Price
$16.80
Change
-$0.34 (-1.98%)
Updated
Jun 27 closing price
Capitalization
1.69B
45 days until earnings call
CCCC
Price
$1.40
Change
-$0.12 (-7.89%)
Updated
Jun 27 closing price
Capitalization
100.82M
39 days until earnings call
Interact to see
Advertisement

BEAM vs CCCC

Header iconBEAM vs CCCC Comparison
Open Charts BEAM vs CCCCBanner chart's image
Beam Therapeutics
Price$16.80
Change-$0.34 (-1.98%)
Volume$4.49M
Capitalization1.69B
C4 Therapeutics
Price$1.40
Change-$0.12 (-7.89%)
Volume$8.25M
Capitalization100.82M
BEAM vs CCCC Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CCCC commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and CCCC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (BEAM: $16.80 vs. CCCC: $1.40)
Brand notoriety: BEAM and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 238% vs. CCCC: 691%
Market capitalization -- BEAM: $1.69B vs. CCCC: $100.82M
BEAM [@Biotechnology] is valued at $1.69B. CCCC’s [@Biotechnology] market capitalization is $100.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and CCCC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while CCCC’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • CCCC’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CCCC.

Price Growth

BEAM (@Biotechnology) experienced а +0.18% price change this week, while CCCC (@Biotechnology) price change was -1.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

CCCC is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.69B) has a higher market cap than CCCC($101M). BEAM YTD gains are higher at: -32.258 vs. CCCC (-61.111). CCCC has higher annual earnings (EBITDA): -102.74M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. CCCC (215M). CCCC has less debt than BEAM: CCCC (64.4M) vs BEAM (158M). BEAM has higher revenues than CCCC: BEAM (63.6M) vs CCCC (39.8M).
BEAMCCCCBEAM / CCCC
Capitalization1.69B101M1,671%
EBITDA-399.03M-102.74M388%
Gain YTD-32.258-61.11153%
P/E RatioN/AN/A-
Revenue63.6M39.8M160%
Total Cash1.22B215M567%
Total Debt158M64.4M245%
TECHNICAL ANALYSIS
Technical Analysis
BEAMCCCC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCGYX19.810.24
+1.23%
NYLI PineStone Global Equity Class C
NBFCX34.140.27
+0.80%
Neuberger Berman Focus Trust
RYANX137.441.03
+0.76%
Rydex Nova A
PGELX27.110.06
+0.22%
George Putnam Balanced R5
HBLYX14.85N/A
N/A
Hartford Balanced Income Y

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.98%
CRSP - BEAM
71%
Closely correlated
+1.69%
RXRX - BEAM
64%
Loosely correlated
-6.85%
NTLA - BEAM
63%
Loosely correlated
-0.52%
DNLI - BEAM
61%
Loosely correlated
-2.69%
SYRE - BEAM
59%
Loosely correlated
-4.99%
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-7.89%
KYMR - CCCC
56%
Loosely correlated
-3.48%
CRBU - CCCC
55%
Loosely correlated
-6.67%
BEAM - CCCC
53%
Loosely correlated
-1.98%
FATE - CCCC
52%
Loosely correlated
-5.45%
RXRX - CCCC
51%
Loosely correlated
-6.85%
More